Trials / Sponsors / Opna Bio LLC
Opna Bio LLC
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myelo Relapsed Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | 2024-08-22 |
| Terminated | PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects Wi Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2020-09-21 |
| Terminated | PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platin Gynecologic Neoplasms, Epithelial Ovarian Cancer | Phase 1 / Phase 2 | 2020-08-11 |
| Completed | A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) | Phase 1 | 2019-03-19 |
| Completed | A Study of PLX2853 in Advanced Malignancies. Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma | Phase 1 | 2017-09-12 |